$1.43 Billion is the total value of Rhenman & Partners Asset Management AB's 92 reported holdings in Q1 2021. The portfolio turnover from Q4 2020 to Q1 2021 was 20.5% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| HZNP | Sell | HORIZON THERAPEUTICS PUB LTD | $54,764,000 | +24.8% | 595,000 | -0.8% | 3.82% | +6.6% |
| JNJ | Buy | JOHNSON & JOHNSON | $53,414,000 | +195.1% | 325,000 | +182.6% | 3.72% | +152.1% |
| UNH | Buy | UNITED HEALTH GROUP INC | $42,044,000 | +14.2% | 113,000 | +7.6% | 2.93% | -2.4% |
| JAZZ | Buy | JAZZ PHARMACEUTICALS PLC | $41,093,000 | +13.2% | 250,000 | +13.6% | 2.86% | -3.3% |
| ABBV | Sell | ABBVIE INC | $39,825,000 | -25.7% | 368,000 | -26.4% | 2.78% | -36.5% |
| MDT | Buy | MEDTRONIC PLC | $39,574,000 | +5.6% | 335,000 | +4.7% | 2.76% | -9.8% |
| VRTX | Buy | VERTEX PHARMACEUTICALS INC | $36,192,000 | +33.2% | 168,421 | +46.5% | 2.52% | +13.8% |
| TDOC | Buy | TELADOC HEALTH INC | $34,533,000 | +50.2% | 190,000 | +65.2% | 2.41% | +28.4% |
| GH | Buy | GUARDANT HEALTH INC | $34,346,000 | +56.8% | 225,000 | +32.4% | 2.40% | +33.9% |
| ANTM | Buy | ANTHEM INC | $34,100,000 | +32.8% | 95,000 | +18.8% | 2.38% | +13.5% |
| CVS | Buy | CVS HEALTH CORP | $33,854,000 | +18.0% | 450,000 | +7.1% | 2.36% | +0.9% |
| ABT | Buy | ABBOTT LABS | $32,956,000 | +100.7% | 275,000 | +83.3% | 2.30% | +71.5% |
| LLY | Sell | LILLY ELI & CO | $31,759,000 | +4.5% | 170,000 | -5.6% | 2.21% | -10.7% |
| HUM | Buy | HUMANA INC | $28,928,000 | +21.6% | 69,000 | +19.0% | 2.02% | +3.9% |
| CNC | Buy | CENTENE CORP DEL | $26,842,000 | +56.9% | 420,000 | +47.4% | 1.87% | +34.1% |
| CI | Sell | CIGNA CORP NEW | $26,591,000 | -8.8% | 110,000 | -21.4% | 1.85% | -22.0% |
| NKTR | Sell | NEKTAR THERAPEUTICS | $26,144,000 | +13.9% | 1,307,196 | -3.2% | 1.82% | -2.6% |
| BSX | Buy | BOSTON SCIENTIFIC CORP | $25,896,000 | +35.9% | 670,000 | +26.4% | 1.81% | +16.1% |
| MRTX | Buy | MIRATI THERAPEUTICS INC | $25,695,000 | +17.0% | 150,000 | +50.0% | 1.79% | 0.0% |
| ABMD | Buy | ABIOMED INC | $24,861,000 | +21.7% | 78,000 | +23.8% | 1.73% | +4.0% |
| AXNX | Sell | AXONICS MODULATION TECH INC | $24,555,000 | +6.9% | 410,000 | -10.9% | 1.71% | -8.6% |
| NVCR | Buy | NOVOCURE LTD | $23,792,000 | +14.6% | 180,000 | +50.0% | 1.66% | -2.1% |
| EXAS | Buy | EXACT SCIENCES CORP | $23,062,000 | +132.1% | 175,000 | +133.3% | 1.61% | +98.3% |
| GILD | Sell | GILEAD SCIENCES INC | $22,621,000 | +0.9% | 350,000 | -9.1% | 1.58% | -13.8% |
| XLRN | ACCELERON PHARMA INC | $21,698,000 | +6.0% | 160,000 | 0.0% | 1.51% | -9.4% | |
| ISRG | Buy | INTUITIVE SURGICAL INC | $21,429,000 | +274.2% | 29,000 | +314.3% | 1.49% | +219.9% |
| ZBH | Buy | ZIMMER BIOMET HOLDINGS INC | $20,810,000 | +107.8% | 130,000 | +100.0% | 1.45% | +77.6% |
| MRK | Sell | MERCK & CO INC | $20,814,000 | -26.0% | 270,000 | -21.5% | 1.45% | -36.8% |
| BDX | Buy | BECTON DICKINSON & CO | $20,668,000 | +83.6% | 85,000 | +88.9% | 1.44% | +56.8% |
| TMO | Buy | THERMO FISHER SCIENTIFIC INC | $20,537,000 | +60.6% | 45,000 | +63.9% | 1.43% | +37.3% |
| BMY | Sell | BRISTOL MYERS SQUIBB CO | $20,517,000 | -2.7% | 325,000 | -4.4% | 1.43% | -16.9% |
| ABC | New | AMERISOURCEBERGEN CORP | $19,831,000 | – | 167,957 | +100.0% | 1.38% | – |
| COO | Sell | COOPER COS INC | $19,205,000 | -3.9% | 50,000 | -9.1% | 1.34% | -17.9% |
| ALNY | Buy | ALNYLAM PHARMACEUTICALS INC | $19,061,000 | +31.3% | 135,000 | +20.9% | 1.33% | +12.2% |
| MGNX | Sell | MACROGENICS INC | $17,363,000 | +21.5% | 545,160 | -12.8% | 1.21% | +3.9% |
| MCK | New | MCKESSON CORP | $17,164,000 | – | 88,000 | +100.0% | 1.20% | – |
| ESPR | ESPERION THERAPEUTICS INC NE | $16,612,000 | +7.9% | 592,225 | 0.0% | 1.16% | -7.8% | |
| BAX | Sell | BAXTER INTL INC | $16,025,000 | -2.6% | 190,000 | -7.3% | 1.12% | -16.8% |
| ITCI | Sell | INTRA CELLULAR THERAPIES INC | $15,532,000 | -2.3% | 457,778 | -8.4% | 1.08% | -16.5% |
| NBIX | Buy | NEUROCRINE BIOSCIENCES INC | $15,074,000 | +4.8% | 155,000 | +3.3% | 1.05% | -10.4% |
| HCA | HCA HEALTHCARE INC | $14,126,000 | +14.5% | 75,000 | 0.0% | 0.98% | -2.1% | |
| BHVN | Sell | BIOHAVEN PHARMACTL HLDG CO L | $13,699,000 | -32.0% | 200,419 | -14.7% | 0.96% | -41.9% |
| BMRN | Sell | BIOMARIN PHARMACEUTICAL INC | $13,592,000 | -69.6% | 180,000 | -64.7% | 0.95% | -74.0% |
| AERI | Sell | AERIE PHARMACEUTICALS INC | $13,403,000 | +16.7% | 750,000 | -11.8% | 0.94% | -0.2% |
| APLS | APELLIS PHARMACEUTICALS INC | $11,586,000 | -25.0% | 270,000 | 0.0% | 0.81% | -35.9% | |
| LIVN | Sell | LIVANOVA PLC | $11,428,000 | -9.2% | 155,000 | -18.4% | 0.80% | -22.3% |
| SGEN | Buy | SEAGEN INC | $11,109,000 | -2.4% | 80,000 | +23.1% | 0.78% | -16.6% |
| XNCR | Sell | XENCOR INC | $10,119,000 | -10.6% | 235,000 | -9.4% | 0.71% | -23.5% |
| SGMO | Sell | SANGAMO THERAPEUTICS INC | $9,585,000 | -25.3% | 765,000 | -6.9% | 0.67% | -36.1% |
| REGN | Sell | REGENERON PHARMACEUTICALS | $9,463,000 | -51.0% | 20,000 | -50.0% | 0.66% | -58.1% |
| IOVA | Sell | IOVANCE BIOTHERAPEUTICS INC | $9,340,000 | -37.1% | 295,000 | -7.8% | 0.65% | -46.2% |
| EW | Sell | EDWARDS LIFESCIENCES CORP | $9,200,000 | -19.3% | 110,000 | -12.0% | 0.64% | -31.1% |
| ACCD | Buy | ACCOLADE INC | $9,074,000 | +39.1% | 200,000 | +33.3% | 0.63% | +19.0% |
| RDUS | Sell | RADIUS HEALTH INC | $8,970,000 | +4.2% | 430,000 | -10.8% | 0.62% | -11.0% |
| ONEM | New | 1LIFE HEALTHCARE INC | $7,816,000 | – | 200,000 | +100.0% | 0.54% | – |
| GTHX | Buy | G1 THERAPEUTICS INC | $7,820,000 | +81.1% | 325,000 | +35.4% | 0.54% | +54.8% |
| DVAX | Sell | DYNAVAX TECHNOLOGIES CORP | $7,728,000 | +87.6% | 786,211 | -15.1% | 0.54% | +60.4% |
| EPIX | Buy | ESSA PHARMA INC | $7,553,000 | +304.1% | 260,000 | +65.9% | 0.53% | +246.7% |
| SILK | Buy | SILK ROAD MEDICAL INC | $7,395,000 | -6.1% | 146,000 | +16.8% | 0.52% | -19.6% |
| FGEN | Buy | FIBROGEN INC | $6,942,000 | +29.1% | 200,000 | +37.9% | 0.48% | +10.3% |
| PHAT | PHATHOM PHARMACEUTICALS INC | $6,573,000 | +13.1% | 175,000 | 0.0% | 0.46% | -3.4% | |
| SWAV | Sell | SHOCKWAVE MEDICAL INC | $6,513,000 | +4.7% | 50,000 | -16.7% | 0.45% | -10.6% |
| MGTX | MEIRAGTX HOLDINGS PLC | $6,494,000 | -4.7% | 450,000 | 0.0% | 0.45% | -18.5% | |
| ADVM | Buy | ADVERUM BIOTECHNOLOGIES INC | $6,409,000 | -5.4% | 650,000 | +4.0% | 0.45% | -19.2% |
| OSH | Buy | OAK STR HEALTH INC | $6,241,000 | +70.1% | 115,000 | +91.7% | 0.44% | +45.5% |
| INOV | New | INOVALON HLDGS INC | $6,188,000 | – | 215,000 | +100.0% | 0.43% | – |
| RVNC | REVANCE THERAPEUTICS INC | $6,149,000 | -1.4% | 220,000 | 0.0% | 0.43% | -15.7% | |
| ALXN | Sell | ALEXION PHARMACEUTICALS INC | $6,116,000 | -67.4% | 40,000 | -66.7% | 0.43% | -72.2% |
| ZLAB | New | ZAI LAB LTDadr | $6,004,000 | – | 45,000 | +100.0% | 0.42% | – |
| RPRX | Sell | ROYALTY PHARMA PLC | $5,671,000 | -54.7% | 130,000 | -48.0% | 0.40% | -61.3% |
| BIIB | Sell | BIOGEN INC | $5,455,000 | -44.3% | 19,500 | -51.2% | 0.38% | -52.4% |
| HCAT | New | HEALTH CATALYST INC | $5,379,000 | – | 115,000 | +100.0% | 0.38% | – |
| RIGL | Sell | RIGEL PHARMACEUTICALS INC | $5,198,000 | -14.5% | 1,520,000 | -12.5% | 0.36% | -27.0% |
| ANNX | Buy | ANNEXON INC | $5,011,000 | +54.0% | 180,000 | +38.5% | 0.35% | +31.7% |
| RCM | New | R1 RCM INC | $4,936,000 | – | 200,000 | +100.0% | 0.34% | – |
| MYOV | Buy | MYOVANT SCIENCES LTD | $4,631,000 | -16.2% | 225,000 | +12.5% | 0.32% | -28.4% |
| STXS | Buy | STEREOTAXIS INC | $4,599,000 | +60.1% | 684,402 | +21.3% | 0.32% | +37.2% |
| IMGN | New | IMMUNOGEN INC | $4,455,000 | – | 550,000 | +100.0% | 0.31% | – |
| ARNA | Sell | ARENA PHARMACEUTICALS INC | $4,163,000 | -22.6% | 60,000 | -14.3% | 0.29% | -33.9% |
| NUAN | New | NUANCE COMMUNICATIONS INC | $3,928,000 | – | 90,000 | +100.0% | 0.27% | – |
| ALKS | ALKERMES PLC | $3,911,000 | -6.4% | 209,354 | 0.0% | 0.27% | -19.9% | |
| IONS | New | IONIS PHARMACEUTICALS INC | $3,372,000 | – | 75,000 | +100.0% | 0.24% | – |
| VRAY | VIEWRAY INC | $3,371,000 | +13.8% | 775,000 | 0.0% | 0.24% | -2.9% | |
| AMWL | Buy | AMERICAN WELL CORPcl a | $3,373,000 | +121.9% | 194,165 | +223.6% | 0.24% | +89.5% |
| PHR | New | PHREESIA INC | $3,126,000 | – | 60,000 | +100.0% | 0.22% | – |
| GKOS | Sell | GLAUKOS CORP | $2,938,000 | -68.8% | 35,000 | -72.0% | 0.20% | -73.3% |
| GDRX | Buy | GOODRX HLDGS INC | $2,927,000 | +107.3% | 75,000 | +114.3% | 0.20% | +77.4% |
| VEEV | New | VEEVA SYS INC | $2,874,000 | – | 11,000 | +100.0% | 0.20% | – |
| NXGN | New | NEXTGEN HEALTHCARE INC | $2,715,000 | – | 150,000 | +100.0% | 0.19% | – |
| DCPH | DECIPHERA PHARMACEUTICALS INC | $2,690,000 | -21.4% | 60,000 | 0.0% | 0.19% | -32.6% | |
| EPZM | EPIZYME INC | $2,308,000 | -19.8% | 265,000 | 0.0% | 0.16% | -31.5% | |
| PIRS | PIERIS PHARMACEUTICALS INC | $771,000 | +2.8% | 300,000 | 0.0% | 0.05% | -11.5% | |
| CTIC | Exit | CTI BIOPHARMA CORP | $0 | – | -300,000 | -100.0% | -0.08% | – |
| AUPH | Exit | AURINIA PHARMACEUTICALS INC | $0 | – | -125,000 | -100.0% | -0.14% | – |
| FPRX | Exit | FIVE PRIME THERAPEUTICS INC | $0 | – | -250,000 | -100.0% | -0.35% | – |
| AGIO | Exit | AGIOS PHARMACEUTICALS INC | $0 | – | -130,000 | -100.0% | -0.46% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-05-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| UNITEDHEALTH GROUP INC | 40 | Q3 2023 | 4.0% |
| BIOMARIN PHARMACEUTICAL INC | 40 | Q3 2023 | 5.0% |
| ALKERMES PLC | 40 | Q3 2023 | 3.3% |
| LILLY ELI & CO | 39 | Q3 2023 | 5.8% |
| CVS HEALTH CORP | 39 | Q3 2023 | 3.5% |
| INTRA-CELLULAR THERAPIES INC | 39 | Q3 2023 | 2.4% |
| EDWARDS LIFESCIENCES CORP | 39 | Q3 2023 | 1.7% |
| VERTEX PHARMACEUTICALS INC | 38 | Q3 2023 | 4.3% |
| REVANCE THERAPEUTICS INC | 38 | Q3 2023 | 0.9% |
| ABBVIE INC | 37 | Q3 2023 | 4.4% |
View Rhenman & Partners Asset Management AB's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-13 |
| 13F-HR/A | 2023-11-13 |
| 13F-HR | 2023-11-09 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-12 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-11 |
View Rhenman & Partners Asset Management AB's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.